Healthcare's Carbon Footprint: How Hospitals and Pharma Drive 4.4% of Global CO2 Emissions

The healthcare sector accounts for roughly 4.4% of global CO2 emissions, a figure that exceeds aviation and continues to rise. A 2026 review shows that pharmaceutical companies alone produce emissions equivalent to over 514 coal power plants annually. The bulk of these emissions come from Scope 3 sources like supply chains, clinical trials, and product distribution, which make up as much as 80% of a pharma company's total carbon footprint. Mandatory ESG reporting is reshaping how healthcare companies track and disclose emissions. The EU's Corporate Sustainability Reporting Directive now requires data-driven disclosures with third-party assurance, pushing firms to build internal controls similar to SOX compliance. While a recent EU Omnibus package may reduce the number of companies directly covered, the largest global pharma and biotech firms remain in scope. This regulatory shift is forcing the sector to move beyond voluntary sustainability reports and toward verifiable, auditable emissions data across the full value chain.